Repositori institucional URV
Belongs to TFG:SerieGeneralBIOT collection
TITLE:
Evaluación biotecnológica de péptidos cíclicos heteroquirales como inhibidores de la interacción PD1/PD-L1 - TFG:3022
Handle:
https://hdl.handle.net/20.500.11797/TFG3022
Student:
Roig Soriano, Xavier
Language:
spa
Title in original language:
Evaluación biotecnológica de péptidos cíclicos heteroquirales como inhibidores de la interacción PD1/PD-L1
Title in different languages:
Biotechnological evaluation of heterochiral cyclic peptides as inhibitors of PD-1/PD-L1 interaction
Keywords:
PD-1, PD-L1 and peptides
Subject:
Bioquímica i tecnologia
Abstract:
Programmed cell death protein 1 (PD-1) is a receptor found on the cytoplasmic membrane of cells of the immune system (IS). Cells interact with PD-1 through their natural ligand, PD-L1. With this interaction the immune system recognizes healthy cells and inhibits its action against them. If this interaction does not occur, it will trigger the response to eliminate them. In some types of cancer, has been detected an increased expression of PD-L1 simulating a healthy cell, as a cancer adaptation mechanism to escape the immune response. This project focuses on evaluating peptides that can block this interaction. In this way, it would prevent cancer cells from being perceived as healthy cells and, therefore, the immune system could attack tumour proliferation. The anti-PD-1 peptides have been evaluated by three different biophysical techniques: Microscale Thermophoresis (MST), Isothermal Titration Calorimetry (ITC) and Nuclear Magnetic Resonance (NMR). Among all the peptides tested, PD-i3, PD-i5 and PD-i6 stood out, which presented affinity values of the order of the natural ligand and, therefore, can compete to inhibit endogenous interaction. The zone of interaction with these peptides on PD-1 surface was also verified by NMR. Consequently, these peptides are promising candidates for interfering with the PD-1 / PD-L1 interaction and, with this, achieve an immune response against.
Project director:
Blay Olivé, Maria Teresa; Guardiola Bagán, Salvador
Department:
Bioquímica i Biotecnologia
Education area(s):
Biotecnologia
Entity:
Universitat Rovira i Virgili (URV)
TFG credits:
9
Creation date in repository:
2020-12-21
Work's public defense date:
2020-06-21
Academic year:
2019-2020
Confidenciality:
No
Access rights:
info:eu-repo/semantics/openAccess
Type:
info:eu-repo/semantics/bachelorThesis
Contributor:
Blay Olivé, Maria Teresa; Guardiola Bagán, Salvador
Títol:
Evaluación biotecnológica de péptidos cíclicos heteroquirales como inhibidores de la interacción PD1/PD-L1
Subject:
Bioquímica i tecnologia
Language:
spa
Creator:
Roig Soriano, Xavier
Rights:
info:eu-repo/semantics/openAccess
Date:
2020-06-21
Search your record at:
Available files
File
Description
Format
Memòria
Memory
application/pdf
View/Open
Show entire record
Go back
All objects of this collection
Information
© 2011 Universitat Rovira i Virgili
Legal
Accessibility
Contact